SAN DIEGO, CA / ACCESS Newswire / March 26, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the year and quarter ended December 31, 2025. Fiscal 2025, Fourth Quarter 2025 and Recent Financial and Operating Highlights Generated revenue of $13.8 million for fiscal 2025 compared to $15.7 milli ...

Core Viewpoint - CV Sciences, Inc. supports President Trump's Executive Order aimed at enhancing cannabidiol research to better inform patients and doctors [1] Group 1: Company Overview - CV Sciences, Inc. is a leading consumer wellness company that specializes in hemp extracts and other scientifically-backed natural ingredients and products [1] Group 2: Industry Impact - The Executive Order directs agencies within the Department of Health and Human Services to facilitate access to full-spectrum CBD products for Americans based on research methods utilizing real-world evidence [1]

Core Insights - CV Sciences, Inc. is a leading consumer wellness company focused on hemp extracts and science-backed natural products [1] Financial Results Announcement - The company will release its financial results for the third quarter ended September 30, 2025, after the stock market closes on November 13, 2025 [1] - A conference call with the investment community is scheduled for 1:30 p.m. on the same day [1]